The costs and benefits of cannabis control policies
© 2020, AICHServier GroupCopyright © 2020 AICH Servier Group. All rights reserved..
As is the case for most drugs, cannabis use has costs and benefits, and so do the policies that attempt to minimize the first and maximize the second. This article summarizes what we know about the harmful effects of recreational cannabis use and the benefits of medical cannabis use under the policy of prohibition that prevailed in developed countries until 2012. It outlines three broad ways in which cannabis prohibition may be relaxed, namely, the depenalization of personal possession and use, the legalization of medical use, and the legalization of adult recreational use. It reviews evidence to date on the impacts of each of these forms of liberalization on the costs and benefits of cannabis use. It makes some plausible conjectures about the future impacts of the commercialization of cannabis using experience from the commercialization of the alcohol, tobacco, and gambling industries. Cannabis policy entails unavoidable trade-offs between competing social values in the face of considerable uncertainty about the effects that more liberal cannabis policies will have on cannabis use and its consequences for better or worse.
.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
Dialogues in clinical neuroscience - 22(2020), 3 vom: 01. Sept., Seite 281-287 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hall, Wayne [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adverse effect |
---|
Anmerkungen: |
Date Completed 11.10.2021 Date Revised 11.10.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.31887/DCNS.2020.22.3/whall |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM317305441 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM317305441 | ||
003 | DE-627 | ||
005 | 20231225163005.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.31887/DCNS.2020.22.3/whall |2 doi | |
028 | 5 | 2 | |a pubmed24n1057.xml |
035 | |a (DE-627)NLM317305441 | ||
035 | |a (NLM)33162771 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hall, Wayne |e verfasserin |4 aut | |
245 | 1 | 4 | |a The costs and benefits of cannabis control policies |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.10.2021 | ||
500 | |a Date Revised 11.10.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020, AICHServier GroupCopyright © 2020 AICH Servier Group. All rights reserved. | ||
520 | |a As is the case for most drugs, cannabis use has costs and benefits, and so do the policies that attempt to minimize the first and maximize the second. This article summarizes what we know about the harmful effects of recreational cannabis use and the benefits of medical cannabis use under the policy of prohibition that prevailed in developed countries until 2012. It outlines three broad ways in which cannabis prohibition may be relaxed, namely, the depenalization of personal possession and use, the legalization of medical use, and the legalization of adult recreational use. It reviews evidence to date on the impacts of each of these forms of liberalization on the costs and benefits of cannabis use. It makes some plausible conjectures about the future impacts of the commercialization of cannabis using experience from the commercialization of the alcohol, tobacco, and gambling industries. Cannabis policy entails unavoidable trade-offs between competing social values in the face of considerable uncertainty about the effects that more liberal cannabis policies will have on cannabis use and its consequences for better or worse. | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a adverse effect | |
650 | 4 | |a cannabis policy | |
650 | 4 | |a legalization | |
650 | 4 | |a public health impact | |
650 | 7 | |a Medical Marijuana |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Dialogues in clinical neuroscience |d 1999 |g 22(2020), 3 vom: 01. Sept., Seite 281-287 |w (DE-627)NLM156933519 |x 1958-5969 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2020 |g number:3 |g day:01 |g month:09 |g pages:281-287 |
856 | 4 | 0 | |u http://dx.doi.org/10.31887/DCNS.2020.22.3/whall |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 22 |j 2020 |e 3 |b 01 |c 09 |h 281-287 |